In HD, an emerging area of interest concerns peripherin, rich in basic residues, which may modulate membrane surface proton capacity and promote non-bilayer lipid structures that could, in principle, mitigate bioenergetic deficits relevant to PD and HD pathology [209,210]. The gene discussed is PRPH; the disease is Huntington disease.